BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7147362)

  • 1. Evaluation of doxorubicin cardiotoxicity in patients treated intermittently with beta-methyldigoxin.
    Villani F; Comazzi R; Di Fronzo G; Bertuzzi A; Guindani A
    Tumori; 1982 Aug; 68(4):349-53. PubMed ID: 7147362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cardiac activity and pharmacokinetic analysis of 3H-adriamycin in patients pretreated with beta-methyldigoxin.
    Di Fronzo G; Bertuzzi A; Ronchi E; Villani FP; Ronchetti L
    Cancer Chemother Pharmacol; 1979; 2(3):169-73. PubMed ID: 455570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of action of beta-methyldigoxin and digoxin utilizing systolic time intervals.
    Katdare AD; Namjoshi SA; Nair KG
    J Int Med Res; 1980; 8(1):50-5. PubMed ID: 7358204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum levels of beta-methyldigoxin and contractile efficiency of the myocardium evaluated with systolic polygraphy and determination of cardiac output].
    Pelosi G; Bracchi G; Orazio S; Cereda A
    Minerva Med; 1981 Feb; 72(4-5):225-31. PubMed ID: 7010220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of the interaction between prajmalium bitartrate and beta-methyldigoxin].
    Haasis R; Mikulla A; Roth W
    Med Welt; 1980 Oct; 31(43):1560-2. PubMed ID: 7007790
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of early doxorubicin-induced cardiotoxicity by means of systolic time intervals.
    Villani F; Beretta G; Guindani A
    Cancer Chemother Pharmacol; 1979; 3(4):249-51. PubMed ID: 535135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia.
    Al-Ismail S; Whittaker JA
    Br Med J; 1979 May; 1(6175):1392-5. PubMed ID: 286623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac effects of a single daily dose of 0.15 mg and 0.20 mg of beta-methyldigoxin].
    Belz GG; Wintrich R
    Z Kardiol; 1984 Jan; 73(1):29-33. PubMed ID: 6367246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin cardiotoxicity. Prognostic value of the systolic time intervals.
    Chaudron JM; Beauduin M; Delwiche JP; Delannoy A; Luwaert R; Majois F; Lebacq EG; Pluygers E
    Acta Cardiol; 1982; 37(2):105-15. PubMed ID: 6980547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative comparison of the magnitude and course of action of B-methyldigoxin and digoxin (a study based on systolic time intervals).
    Dalal S; Bhatia ML
    J Assoc Physicians India; 1978 May; 26(5):361-6. PubMed ID: 730715
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction between verapamil and beta-methyldigoxin. Study by 86Rubidium uptake in erythrocytes.
    De Cesaris R; Balestrazzi M; Chiarappa R; Ranieri G
    Int J Clin Pharmacol Res; 1983; 3(2):107-9. PubMed ID: 6679512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects soon after intravenous beta-methyldigoxin.
    Mahar L; Rowland E; Curry P; Krikler D
    Eur J Cardiol; 1979 Mar; 9(3):241-9. PubMed ID: 421724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systolic time intervals and echocardiography in monitoring adriamycin-treated tumor patients].
    Schott G
    Z Gesamte Inn Med; 1991 Jun; 46(8):280-2. PubMed ID: 1897287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Digitalization without saturation dose using methyldigoxin. Experiences with 29 patients].
    Salvadè G; Tartini R; Moccetti T
    Schweiz Med Wochenschr; 1982 Dec; 112(50):1825-8. PubMed ID: 7156964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
    Rameis H; Bonelli J; Waginger H; Hruby K
    Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between myocardial uptake and actions in heart failure of methyldigoxin.
    Hayward R; Greenwood H; Stephens J; Hamer J
    Br J Clin Pharmacol; 1983 Jan; 15(1):41-8. PubMed ID: 6849743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of diagitalis on the behavior of systolic time intervals (STI) during atrial electrostimulation (AE) in subjects with ischemic cardiopathy].
    De Caprio L; Rengo F; Bonaduce D; Piscione F; Scarafile P; Carlomango A; Ferro G; Petretta M
    Boll Soc Ital Cardiol; 1977; 22(10):1843-53. PubMed ID: 753316
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of daunomycin on myocardial contractility and on the action of beta-methyldigoxin.
    Bossa R; Galatulas I; Spiti R
    Pharmacology; 1980; 21(6):400-2. PubMed ID: 7220592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quadratic analysis of left ventricular ejection phase volume using a M-mode echocardiogram, and the effects of beta-methyldigoxin, nifedipine, physical exercise and propranolol on new parameters].
    Suzuki K
    Nihon Ika Daigaku Zasshi; 1988 Dec; 55(6):527-38. PubMed ID: 3209669
    [No Abstract]   [Full Text] [Related]  

  • 20. Amplification of serotonin-induced contractions of isolated porcine coronary arteries after pretreatment with therapeutic doses of beta-methyldigoxin.
    Hoang ND; Sick P
    Eur J Pharmacol; 1987 Mar; 135(1):89-91. PubMed ID: 3569427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.